Zacks Research Has Negative Outlook for UNH Q2 Earnings

UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Equities researchers at Zacks Research reduced their Q2 2025 earnings per share estimates for UnitedHealth Group in a note issued to investors on Thursday, May 1st. Zacks Research analyst D. Chatterjee now expects that the healthcare conglomerate will earn $5.93 per share for the quarter, down from their previous forecast of $7.49. The consensus estimate for UnitedHealth Group's current full-year earnings is $29.54 per share. Zacks Research also issued estimates for UnitedHealth Group's Q3 2025 earnings at $6.66 EPS, Q4 2025 earnings at $6.28 EPS, FY2025 earnings at $26.07 EPS, Q1 2026 earnings at $6.49 EPS, Q2 2026 earnings at $6.12 EPS, Q3 2026 earnings at $7.51 EPS, FY2026 earnings at $29.45 EPS, Q1 2027 earnings at $7.49 EPS and FY2027 earnings at $33.28 EPS.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 earnings per share.

Other analysts also recently issued reports about the company. Truist Financial reduced their target price on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research note on Monday, April 21st. Mizuho upped their target price on UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Barclays decreased their price target on shares of UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Oppenheimer dropped their price target on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a research report on Monday, April 21st. Finally, Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Four research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $596.86.

UnitedHealth Group Trading Down 0.5 %

Shares of NYSE:UNH traded down $2.04 during mid-day trading on Monday, hitting $389.02. The company had a trading volume of 806,316 shares, compared to its average volume of 4,653,258. UnitedHealth Group has a one year low of $385.70 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $354.10 billion, a PE ratio of 25.10, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The firm has a fifty day moving average price of $491.52 and a 200 day moving average price of $525.18.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Sugarloaf Wealth Management LLC increased its holdings in UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock valued at $4,025,000 after buying an additional 1,193 shares during the period. Signal Advisors Wealth LLC boosted its position in shares of UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock worth $4,611,000 after purchasing an additional 1,051 shares in the last quarter. Waycross Partners LLC grew its stake in UnitedHealth Group by 2.4% during the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after purchasing an additional 658 shares during the last quarter. Czech National Bank lifted its stake in UnitedHealth Group by 6.1% during the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock valued at $100,937,000 after acquiring an additional 11,426 shares during the period. Finally, Lmcg Investments LLC grew its holdings in UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock worth $19,210,000 after acquiring an additional 4,022 shares during the period. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.16%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.